Percutaneous parametrial dose escalation in women with advanced cervical cancer: feasibility and efficacy in relation to long-term quality of life
, , , , , , et | 11 sept. 2018
À propos de cet article
Article Category: Research Article
Publié en ligne: 11 sept. 2018
Pages: 320 - 328
Reçu: 14 févr. 2018
Accepté: 09 mai 2018
DOI: https://doi.org/10.2478/raon-2018-0029
© 2018 Sati Akbaba, Jan Tobias Oelmann-Avendano, Tilman Bostel, Harald Rief, Nils Henrik Nicolay, Juergen Debus, Katja Lindel, Robert Foerster, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Sati Akbaba
Department of Radiation Oncology,
University Hospital HeidelbergHeidelberg, Germany
National Center for Radiation Research in Oncology (NCRO),
Heidelberg Institute for Radiation Oncology (HIRO)
Heidelberg, Germany
Jan Tobias Oelmann-Avendano
Department of Radiation Oncology,
University Hospital HeidelbergHeidelberg, Germany
National Center for Radiation Research in Oncology (NCRO),
Heidelberg Institute for Radiation Oncology (HIRO)
Heidelberg, Germany
Tilman Bostel
Department of Radiation Oncology,
University Hospital HeidelbergHeidelberg, Germany
National Center for Radiation Research in Oncology (NCRO),
Heidelberg Institute for Radiation Oncology (HIRO)
Heidelberg, Germany
Harald Rief
Department of Radiation Oncology,
University Hospital HeidelbergHeidelberg, Germany
National Center for Radiation Research in Oncology (NCRO),
Heidelberg Institute for Radiation Oncology (HIRO)
Heidelberg, Germany
Gemeinschaftspraxis Strahlentherapie Bonn-Rhein-SiegBonn, Germany
Nils Henrik Nicolay
Department of Radiation Oncology,
University Hospital HeidelbergHeidelberg, Germany
National Center for Radiation Research in Oncology (NCRO),
Heidelberg Institute for Radiation Oncology (HIRO)
Heidelberg, Germany
Clinical Cooperation Unit Radiation Oncology,
German Cancer Research Center (DKFZ)
Heidelberg, Germany
Department of Radiation Oncology,
University Hospital FreiburgFreiburg, Germany
Juergen Debus
Department of Radiation Oncology,
University Hospital HeidelbergHeidelberg, Germany
National Center for Radiation Research in Oncology (NCRO),
Heidelberg Institute for Radiation Oncology (HIRO)
Heidelberg, Germany
Clinical Cooperation Unit Radiation Oncology,
German Cancer Research Center (DKFZ)
Heidelberg, Germany
Katja Lindel
Department of Radiation Oncology,
University Hospital HeidelbergHeidelberg, Germany
National Center for Radiation Research in Oncology (NCRO),
Heidelberg Institute for Radiation Oncology (HIRO)
Heidelberg, Germany
Department of Radiation Oncology,
Staedtisches Klinikum Karlsruhe
Karlsruhe, Germany
Robert Foerster
Department of Radiation Oncology,
University Hospital HeidelbergHeidelberg, Germany
National Center for Radiation Research in Oncology (NCRO),
Heidelberg Institute for Radiation Oncology (HIRO)
Heidelberg, Germany
Department of Radiation Oncology,
University Hospital ZurichZurich, Switzerland